Morgan Stanley reduced its stake in shares of Organovo Holdings, Inc. (NASDAQ:ONVO) by 9.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 501,532 shares of the company’s stock after selling 51,016 shares during the period. Morgan Stanley’s holdings in Organovo Holdings were worth $1,594,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in Organovo Holdings by 8.5% in the first quarter. Vanguard Group Inc. now owns 4,250,017 shares of the company’s stock valued at $13,515,000 after buying an additional 333,034 shares during the period. UBS Group AG increased its stake in Organovo Holdings by 31.3% in the first quarter. UBS Group AG now owns 1,289,100 shares of the company’s stock valued at $4,099,000 after buying an additional 306,982 shares during the period. Norges Bank acquired a new stake in Organovo Holdings during the fourth quarter valued at approximately $1,030,000. Geode Capital Management LLC increased its stake in Organovo Holdings by 44.6% in the first quarter. Geode Capital Management LLC now owns 955,299 shares of the company’s stock valued at $3,037,000 after buying an additional 294,861 shares during the period. Finally, Bank of New York Mellon Corp increased its stake in Organovo Holdings by 10.2% in the first quarter. Bank of New York Mellon Corp now owns 466,233 shares of the company’s stock valued at $1,482,000 after buying an additional 43,061 shares during the period. Hedge funds and other institutional investors own 23.94% of the company’s stock.

Organovo Holdings, Inc. (ONVO) traded down 1.44% during mid-day trading on Friday, reaching $2.05. 707,584 shares of the company traded hands. Organovo Holdings, Inc. has a 52-week low of $1.75 and a 52-week high of $4.28. The firm’s 50-day moving average is $2.16 and its 200 day moving average is $2.68.

Organovo Holdings (NASDAQ:ONVO) last posted its earnings results on Wednesday, August 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.10). The company had revenue of $0.99 million for the quarter, compared to analysts’ expectations of $0.92 million. Organovo Holdings had a negative return on equity of 65.49% and a negative net margin of 918.97%. Organovo Holdings’s revenue was up 11.1% compared to the same quarter last year. Equities analysts predict that Organovo Holdings, Inc. will post ($0.39) EPS for the current fiscal year.

WARNING: “Morgan Stanley Decreases Position in Organovo Holdings, Inc. (ONVO)” was published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://www.watchlistnews.com/morgan-stanley-decreases-position-in-organovo-holdings-inc-onvo/1538376.html.

ONVO has been the subject of several research reports. Evercore ISI reiterated an “outperform” rating and issued a $3.75 price target (down previously from $4.00) on shares of Organovo Holdings in a research report on Friday, June 9th. BidaskClub downgraded shares of Organovo Holdings from a “sell” rating to a “strong sell” rating in a research report on Tuesday, July 25th. Jefferies Group LLC reiterated a “buy” rating and issued a $4.00 price target on shares of Organovo Holdings in a research report on Thursday, July 27th. Finally, ValuEngine downgraded shares of Organovo Holdings from a “sell” rating to a “strong sell” rating in a research report on Friday. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. Organovo Holdings has an average rating of “Hold” and an average target price of $6.20.

About Organovo Holdings

Institutional Ownership by Quarter for Organovo Holdings (NASDAQ:ONVO)

Receive News & Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.